CoChat

Statins and Diabetes Risk

Open access
Rahman Chowdhury, Sumon · 2021 · Journal of Endocrinology and Thyroid Research
Cited by 40

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Statins are a class of drugs that inhibit the HMG Co-A reductase enzyme and subsequently reduce the cholesterol levels.HMG Co-A reductase enzyme is involved in the cholesterol synthesis in the liver and accounts for 70% of the production of total body cholesterol.High cholesterol levels attribute to cardiovascular disease in high-risk individuals.Statins have been found to reduce CVD endpoints in the initial stages of the disease (secondary prevention) but evidence is still weak to support statin therapy in those without CVD but with high cholesterol levels (primary prevention).Statins are also associated with certain adverse effects like muscle pain, incident diabetes and elevated liver enzymes and occasionally muscle damage; although very rare.In this review I shall explore one of these adverse effects of statin therapy particularly the link between statins and incident diabetes in the following report and try to shed some light into this controversial topic.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.19080/jetr.2021.05.555674

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 40

Metadata

Authors
Rahman Chowdhury, S.
Venue
Journal of Endocrinology and Thyroid Research
Published
2021-02-25
Volume
5
Issue
5
Pages
79-80
ISSN
2573-2188 (ISSN-L)
OpenAlex
W4232424184
Cited by
40
References
1
FWCI
1.06
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statins and Diabetes Risk. https://app.cochat.ai/papers/10.19080/jetr.2021.05.555674
The paper
Rahman Chowdhury, S. (2021). Statins and Diabetes Risk. Journal of Endocrinology and Thyroid Research. https://doi.org/10.19080/jetr.2021.05.555674

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.